Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

This study has been completed.
Information provided by:
French Innovative Leukemia Organisation Identifier:
First received: May 29, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given